Related Experiment Video
Updated: May 6, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Toxic Epidermal Necrolysis in Pregnancy: A Case Report
Anisha Choudhary1, Murari Bharadwaj2, Archana Barik1
1Obstetrics and Gynecology, Tata Main Hospital, Jamshedpur, IND.
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, severe mucocutaneous adverse drug reactions associated with significant morbidity and mortality. SJS or TEN during pregnancy is rare and presents with unique diagnostic and management challenges, with potential risks to both the mother and fetus. We report a case of a 25-year-old primigravida at 29 weeks of gestation who presented with widespread cutaneous eruptions following ingestion of an over-the-counter herbal medication for headache. Clinical examination revealed extensive erythematous macules involving the face, trunk, limbs and genital region. Based on characteristic clinical features, extent of epidermal detachment, and temporal association with drug exposure, a diagnosis of TEN was established. The patient went into spontaneous preterm labor and delivered a male neonate vaginally. Multidisciplinary management with systemic corticosteroids and supportive care resulted in gradual clinical improvement and complete re-epithelialization. Both the mother and neonate had favorable outcomes. This case highlights the importance of early clinical recognition of TEN in pregnancy and emphasizes that even herbal and alternative medications may precipitate severe cutaneous adverse reactions. Prompt withdrawal of the offending agent, multidisciplinary supportive care, and individualized obstetric management are essential to optimize maternal and fetal outcomes.
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, severe mucocutaneous adverse drug reactions associated with significant morbidity and mortality. SJS or TEN during pregnancy is rare and presents with unique diagnostic and management challenges, with potential risks to both the mother and fetus. We report a case of a 25-year-old primigravida at 29 weeks of gestation who presented with widespread cutaneous eruptions following ingestion of an over-the-counter herbal medication for headache. Clinical examination revealed extensive erythematous macules involving the face, trunk, limbs and genital region. Based on characteristic clinical features, extent of epidermal detachment, and temporal association with drug exposure, a diagnosis of TEN was established. The patient went into spontaneous preterm labor and delivered a male neonate vaginally. Multidisciplinary management with systemic corticosteroids and supportive care resulted in gradual clinical improvement and complete re-epithelialization. Both the mother and neonate had favorable outcomes. This case highlights the importance of early clinical recognition of TEN in pregnancy and emphasizes that even herbal and alternative medications may precipitate severe cutaneous adverse reactions. Prompt withdrawal of the offending agent, multidisciplinary supportive care, and individualized obstetric management are essential to optimize maternal and fetal outcomes.
Related Concept Videos
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Teratogenicity
Drug Toxicity: Risk factors
Drug Toxicity: Dose-Dependent Reactions
Drug Toxicity: Allergic Reactions
Toxidromes: Clinical Features

